(HAI) and Drug-Resistant Germs


June 24, 2020 10:00am-3:00pm

Reducing the Threats of Healthcare Associated Infections (HAI) and Drug-Resistant Germs

Cost $150 – Purchase Registration Below

Using case studies and practical examples, you will identify the threats that confront you and your organization and gain confidence for addressing these very important issues.

Event Details:

This course covers drug-resistant germs that are known to be a serious health threat. The Centers for Disease Control and Prevention (CDC) now says the problem is worse, and more baffling, than previously thought. The CDC also reports that infections are spreading more widely outside hospitals and more disease-causing microorganisms are developing resistance to antibiotics and other drugs. New Federal and State regulations require that effective steps must be taken to reduce the pain, suffering and cost of preventable diseases.

You will learn about these dangerous microorganisms, the threats they pose, and how to develop a plan for preventing and controlling these germs.

Target Audience: Infection control practitioners, nurses, physicians, healthcare facility administrators, home health personnel, nursing home personnel, laboratory personnel, environmental scientists, healthcare environmental services (EVS) personnel, facility management personnel.

Paul J. Pearce, PhD,






President/CEO, Nova Biologics, Inc.

Dr. Pearce is a Board-Certified Microbiologist and President/CEO of Nova Biologicals, Inc., Conroe, TX. He is actively involved in seeking solutions to the problems associated with HAIs, microbial pathogenicity, and disease prevention. His experiences working in hospitals, environmental and clinical laboratories and medical schools provide special insights and solutions for today’s infectious disease problems. Dr. Pearce is a frequent guest on CUTV talk radio and the Donna Drake Show. Dr. Pearce also serves on the Environmental Services Optimization Project Advisory Council, a professional organization dedicated to improving patient quality of care.